The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Vascular Dysfunction and Metabolic Parameters in Polycystic Ovary Syndrome
Abstract
CONTEXT: Polycystic ovary syndrome (PCOS) is associated with insulin resistance (IR) and the metabolic syndrome; however, the cardiovascular (CV) manifestations of PCOS remain unclear. OBJECTIVE: The objective of this study was to examine the relationships between IR, metabolic parameters, androgens, and markers of early CV disease in PCOS. DESIGN: We conducted an observational study examining noninvasive markers of early CV disease in women with PCOS including structural [carotid intimal media thickness (IMT)] and functional measures (arterial function with pulse wave velocity and endothelial function with brachial arterial flow-mediated vasodilation). Metabolic parameters included insulin and glucose during an oral glucose tolerance test and lipid and androgen levels. SETTING: Participants were recruited from the general community. PATIENTS: Eighty overweight women with PCOS who were nonsmokers and not on oral contraceptives or other medications known to affect IR participated in the study. RESULTS: Stepwise regression analysis showed that after adjustment for age and body mass index, IMT was significantly correlated with blood pressure (BP) load (P = 0.03) and inversely with dehydroepiandrosterone sulfate (DHEAS) (P = 0.01). After correction for androgen status, IMT was correlated with fasting glucose and area under curve (AUC) insulin. Flow-mediated vasodilation was inversely related to lipids (P = 0.02), whereas pulse wave velocity was related to BP (P < 0.001), AUC insulin (P = 0.04), and AUC glucose (P = 0.035). CONCLUSION: In overweight women with PCOS, insulin resistance and BP interacted negatively with arterial structural and functional measures. DHEAS correlated inversely with arterial structure, suggesting possible cardioprotective effects of endogenous DHEAS in women with PCOS. Additional research is needed to clarify these findings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which are all exacerbated by obesity.”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [29]
In the citing paper
“individual risk factors for CVD and clinical signs of atherosclerosis, 29,30”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [29]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [29]
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., Ducimetiere, P., & Benetos, A. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1236 · Cited by 3,856
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients
Blacher, J., Asmar, R., Djane, S., London, G. M., & Safar, M. E. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1111 · Cited by 1,493
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
Central Pulse Pressure and Mortality in End-Stage Renal Disease
Safar, M. E., Blacher, J., Pannier, B., Guérin, A. P., Marchais, S. J., Guyonvarc’h, P.-M., & London, G. M. (2002) · Hypertension · doi:10.1161/hy0202.098325 · Cited by 800
Salomaa, V. V., Riley, W. A., Kark, J. D., Nardo, C. J., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 580
Carmina, E., & Lobo, R. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5803 · Cited by 528
Talbott, E. O., Guzick, D. S., Sutton-Tyrrell, K., McHugh-Pemu, K. P., Zborowski, J. V., Remsberg, K. E., & Kuller, L. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2414 · Cited by 511
Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study
Koskinen, P., Mänttäri, M., Manninen, V., Huttunen, J. K., Heinonen, O. P., & Frick, M. H. (1992) · Diabetes Care · doi:10.2337/diacare.15.7.820 · Cited by 509
Flagged first, then by citations
Cited by
Sorted by citations
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Self-citationMoran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Hart, R., & Doherty, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3886 · Cited by 391
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Self-citationMetabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362
Self-citationTeede, H. J., Joham, A. E., Paul, E., Moran, L. J., Loxton, D., Jolley, D., & Lombard, C. (2013) · Obesity · doi:10.1002/oby.20213 · Cited by 351
Self-citationRegensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334
Poly Cystic Ovarian Syndrome: An Updated Overview
Hayek, S. E., Bitar, L., Hamdar, L., Mirza, F., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 342
Female Obesity and Infertility
Talmor, A. J., & Dunphy, B. C. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.10.014 · Cited by 320
The role of low-grade inflammation in the polycystic ovary syndrome
Repaci, A., Gambineri, A., & Pasquali, R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.002 · Cited by 310
Joham, A. E., Teede, H. J., Ranasinha, S., Zoungas, S., & Boyle, J. A. (2015) · Journal of Women s Health · doi:10.1089/jwh.2014.5000 · Cited by 262
Self-citationMeyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr046 · Cited by 175
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.007 · Cited by 165
Agarwal, N., Rice, S., Bolusani, H., Luzio, S. D., Dunseath, G. J., Ludgate, M., & Rees, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1985 · Cited by 162
Orio, F., Palomba, S., Cascella, T., Simone, B. D., Manguso, F., Savastano, S., Russo, T., Tolino, A., Zullo, F., Lombardi, G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0965 · Cited by 149
Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome
Joham, A. E., Ranasinha, S., Zoungas, S., Moran, L., & Teede, H. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2007 · Cited by 155
Self-citationCussons, A. J., Watts, G. F., Burke, V., Shaw, J. E., Zimmet, P. Z., & Stuckey, B. G. A. (2008) · Human Reproduction · doi:10.1093/humrep/den263 · Cited by 140
Kuşçu, N. K., & Var, A. (2009) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340902859315 · Cited by 125
Heutling, D., Schulz, H., Nickel, I., Kleinstein, J., Kaltwaßer, P., Westphal, S., Mittermayer, F., Wolzt, M., Krzyżanowska, K., Randeva, H. S., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0842 · Cited by 117
Joham, A. E., Boyle, J. A., Ranasinha, S., Zoungas, S., & Teede, H. J. (2014) · Human Reproduction · doi:10.1093/humrep/deu020 · Cited by 82
Self-citationSolano, M. E., Sander, V. A., Ho, H., Motta, A. B., & Arck, P. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.09.003 · Cited by 74
Islam, H., Masud, J., Islam, Y. N., & Haque, F. K. M. (2022) · Women s Health · doi:10.1177/17455057221117966 · Cited by 98
Teede, H. J., Meyer, C., Hutchison, S. K., Zoungas, S., McGrath, B. P., & Moran, L. J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.034 · Cited by 68
Self-citationŞahin, Y., Ünlühızarcı, K., Yilmazsoy, A., Yıkılmaz, A., Aygen, E., & Keleştimur, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02985.x · Cited by 67
Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers
Patel, S. S., Truong, U. T., King, M., Ferland, A., Moreau, K. L., Dorosz, J. L., Hokanson, J. E., Wang, H., Kinney, G. L., Maahs, D. M., et al. (2017) · Vascular Medicine · doi:10.1177/1358863x16682107 · Cited by 70
Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review
Sangaraju, S. L., Yepez, D., Grandes, X. A., Manjunatha, R. T., & Habib, S. (2022) · Cureus · doi:10.7759/cureus.25076 · Cited by 77
Cardiometabolic risks in PCOS: a review of the current state of knowledge
Kakoly, N. S., Moran, L., Teede, H. J., & Joham, A. E. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1556094 · Cited by 71
Self-citationTreatment of PCOS in adolescence
Warren-Ulanch, J., & Arslanian, S. A. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.002 · Cited by 62
Moran, L. J., Hutchison, S. K., Meyer, C., Zoungas, S., & Teede, H. J. (2009) · Clinical Science · doi:10.1042/cs20080218 · Cited by 59
Self-citationTalbott, E. O. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1452 · Cited by 58
Diagnostic Criteria for Polycystic Ovarian Syndrome
Broekmans, F. J., & Fauser, B. C. J. M. (2006) · Endocrine · doi:10.1385/endo:30:1:3 · Cited by 56
Chen, M., Chen, C., Yang, J., Chen, C., Ho, H., Yang, W., & Yang, Y. (2010) · Human Reproduction · doi:10.1093/humrep/deq308 · Cited by 56
Carmina, E., & Løbo, R. A. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347408 · Cited by 54
Joham, A. E., Kakoly, N. S., Teede, H. J., & Earnest, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab134 · Cited by 53
Self-citationFlow‐mediated dilatation in overweight and obese women with polycystic ovary syndrome
Brinkworth, G. D., Noakes, M., Moran, L., Norman, R. J., & Clifton, P. M. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01090.x · Cited by 52
Li, R., Yu, G., Yang, D., Li, S., Lu, S., Wu, X., Wei, Z., Song, X., Wang, X., Fu, S., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-76 · Cited by 50
Arikan, S., Akay, H., Bahceci, M., Tuzcu, A., & Gokalp, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.057 · Cited by 49
Choi, Y. S., Yang, H. I., Cho, S., Jung, J. A., Jeon, Y. E., Kim, H. Y., Seo, S. K., & Lee, B. S. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.005 · Cited by 46
Shah, M. Z. U. H., & Shrivastava, V. K. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100160 · Cited by 48
Olaniyi, K. S., Oniyide, A. A., Adeyanju, O. A., Ojulari, L. S., Omoaghe, A. O., & Olaiya, O. E. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115381 · Cited by 44
Kakoly, N. S., Earnest, A., Moran, L., Teede, H. J., & Joham, A. E. (2017) · BMC Medicine · doi:10.1186/s12916-017-0957-7 · Cited by 38
Self-citationCardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights
Westerveld, H. E., Hoogendoorn, M., de Jong, A. W. F., Goverde, A. J., Fauser, B. C. J. M., & Dallinga‐Thie, G. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.009 · Cited by 38
The association of the lipidomic profile with features of polycystic ovary syndrome
Moran, L., Mundra, P. A., Teede, H. J., & Meikle, P. J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0023 · Cited by 37
Self-citationAlpañés, M., Luque‐Ramírez, M., Martínez-García, M. Á., Fernández‐Durán, E., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.12.105 · Cited by 37
Vascular function in the diagnostic categories of polycystic ovary syndrome
Moran, L., Cameron, J. D., Strauss, B. J., & Teede, H. J. (2011) · Human Reproduction · doi:10.1093/humrep/der159 · Cited by 36
Self-citationMetabolic syndrome and cardiometabolic risk in PCOS
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0012-8 · Cited by 36
Anaforoğlu, İ., Algün, E., İnceçayır, Ö., & Ersoy, K. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0019 · Cited by 35
Pamuk, B. Ö., Torun, A. N., Kulaksızoğlu, M., Ertuğrul, D. T., Çiftçi, Ö., Kulaksızoğlu, S., Yıldırım, E., & Demirağ, N. G. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.073 · Cited by 35
Kebapçılar, L., Taner, C. E., Kebapçılar, A. G., Alacacıoğlu, A., & Sarı, İ. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1051-y · Cited by 34
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
Mason, H. D., Colao, A., Blume‐Peytavi, U., Rice, S., Qureshi, A., Pellatt, L. J., Orio, F., & Atkin, S. L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03329.x · Cited by 33
Soyman, Z., Noyan, V., Tulmaç, M., Yücel, A., Sağsöz, N., Bayrak, T., Bayrak, A., & Çakır, E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.011 · Cited by 32
Chiu, W.-L., Boyle, J. A., Vincent, A. J., Teede, H. J., & Moran, L. (2016) · Neuroendocrinology · doi:10.1159/000455233 · Cited by 31
Self-citationHoang, V., Bi, J., MohanKumar, S. M. J., & Vyas, A. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126119 · Cited by 30
Silva, R. D. C., Pardini, D., & Kater, C. E. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200014 · Cited by 35
Sex Steroid Hormones and Reproductive Disorders
Fauser, B. C. J. M., Laven, J. S. E., Tarlatzis, B. C., Moley, K. H., Critchley, H., Taylor, R. N., Berga, S. L., Mermelstein, P. G., Devroey, P., Gianaroli, L., et al. (2011) · Reproductive Sciences · doi:10.1177/1933719111405068 · Cited by 30
Paschou, S. Α., Palioura, E., Ioannidis, D., Anagnostis, P. G., Panagiotakou, A., Loi, V., Karageorgos, G., Goulis, D. G., & Vryonidou, A. (2017) · Endocrine Connections · doi:10.1530/ec-17-0239 · Cited by 26
Keller, J., Mandalà, M., Casson, P. R., & Osol, G. (2011) · Endocrinology · doi:10.1210/en.2011-1424 · Cited by 24
Dagre, A. G., Lekakis, J., Mihas, C. C., Protogerou, A. D., Thalassinou, L., Tryfonopoulos, D. J., Douridas, G. N., Papamichael, C. M., & Alevizaki, M. K. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02153 · Cited by 22
Göde, F., Karagöz, Ç., Posacı, C., Saatli, B., Uysal, D., Seçil, M., & Akdeniz, B. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1790-9 · Cited by 21
Shah, M. Z. U. H., Shrivastava, V. K., & Mir, M. A. (2022) · Obesity Medicine · doi:10.1016/j.obmed.2022.100392 · Cited by 20
de Medeiros, S. F., de Medeiros, M. A. S., Barbosa, B., & Yamamoto, M. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0045 · Cited by 15
Insulin-sensitisers in the treatment of polycystic ovary syndrome
Teede, H. J., Meyer, C., & Norman, R. J. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.14.2419 · Cited by 18
Self-citationHsiu, H., Hsu, W.-C., Wu, Y., Hsu, C., & Chen, C. (2013) · Microcirculation · doi:10.1111/micc.12095 · Cited by 15
Kaya, M. G., Günebakmaz, Ö., Zencır, C., Yilmazsoy, A., Karadag, M., Topsakal, R., Ergin, A., & Keleştimur, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.04.002 · Cited by 13
The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women
Ilie, I. R. P., Pepene, C. E., Marian, I., Mocan, T., Hazi, G. M., Dragotoiu, G., Ilie, R., MOCAN, L. C., & Duncea, I. (2010) · Open Medicine · doi:10.2478/s11536-010-0054-1 · Cited by 11
Increased circulating urocortin-3 levels is associated with polycystic ovary syndrome
Temür, M., Yılmaz, Ö., Aksun, S., Özbay, P. Ö., Çalan, M., Küme, T., Karakulak, M., & Korkmaz, H. A. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1110135 · Cited by 11
Kim, J., Choi, S., Park, B., Park, H. E., Lee, H., Kim, M.-J., Kim, S. M., Hwang, K. R., & Choi, Y. M. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1561654 · Cited by 11
Female Infertility and Cardiovascular Risk - A Hype or an Underestimated Reality?
Bosdou, J. Κ., Anagnostis, P. G., Lainas, G. T., & Kolibianakis, E. M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200821114552 · Cited by 11
Ilie, I. R. P., Pepene, C. E., Duncea, I., & Ilie, R. (2008) · Open Medicine · doi:10.2478/s11536-008-0044-8 · Cited by 10
Shah, M. Z. U. H., Shrivastava, V. K., & Mir, M. A. (2023) · Obesity Medicine · doi:10.1016/j.obmed.2023.100485 · Cited by 8
Polycystic ovary syndrome as a developmental disorder
Goverde, A. J., Westerveld, H. E., Veltman-Verhulst, S. M., & Fauser, B. C. J. M. (2008) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.3.6.775 · Cited by 8
Temür, M., Özbay, P. Ö., Aksun, S., Yılmaz, Ö., Çift, T., Üstünel, S., & Çalan, M. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4493-7 · Cited by 7
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · doi:10.1007/s00108-006-1776-7 · Cited by 7
Korun, Z. E. U., Göçmez, S. S., Rençber, S. F., Sarıhan, K. K., ERALDEMİR, F. C., & Şahin, D. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01392-9 · Cited by 5
Polycystic ovary syndrome: An updated review
Priya, M., Nanthini, A., & BINI, K. P. (2019) · International Journal of Health & Allied Sciences · doi:10.4103/ijhas.ijhas_9_19 · Cited by 5
Familial aggregation of circulating c-reactive protein in polycystic ovary syndrome
Sasidevi, A., Vellanki, P., Kunselman, A. R., Raja-Khan, N. T., Dunaif, A. E., & Legro, R. S. (2012) · Human Reproduction · doi:10.1093/humrep/des416 · Cited by 5
The link between polycystic ovary syndrome and Type 2 diabetes: what do we know today?
Sathyapalan, T., & Atkin, S. L. (2011) · Diabetes Management · doi:10.2217/dmt.11.59 · Cited by 3
Insulin sensitizers in the treatment of polycystic ovary syndrome
Teede, H. J. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.006 · Cited by 3
Self-citationDas polyzystische Ovarsyndrom: Prototyp eines kardiometabolischen Syndroms
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · Cited by 2
Zaki, M. E., Kholoussi, S., Ismail, S. M., Raouf, H. A., Helwa, I., Hassan, N. A.-M., Youness, E. R., Mohamed, N., Kamal, S., Yousef, W., et al. (2015) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2015.05.007 · Cited by 2
Cardiovascular Disease and Inflammation
Orio, F., Diamanti‐Kandarakis, E., & Palomba, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_13 · Cited by 2
Okifo, F., Pal, L., Mushi, M., & Stachenfeld, N. S. (2025) · Journal of Women s Health · doi:10.1177/15409996251376161 · Cited by 1
Das polyzystische Ovarsyndrom – Metabolische Konsequenzen
Tan, S., Hahn, S., & Janssen, O. E. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111466 · Cited by 1
Kelley, C. E., Brown, A. J., & Setji, T. L. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.941814 · Cited by 1
Non-expression of androgen receptors in the carotid intimal medial zone
Ogeng’o, J. A., Ongeti, K. W., & Saidi, H. (2012) · Cited by 1
Long term complications of Polycystic ovary syndrome
Kachhawa, G. (2017) · Global Journal of Reproductive Medicine · doi:10.19080/gjorm.2017.02.555577 · Cited by 1
Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
Бурка, О. А., Бобрик, М. И., Reznichenko, V. M., & Tutchenko, T. М. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.47.35-42 · Cited by 1
The Polycystic Ovary Syndrome Status - A Risk Factor for Future Cardiovascular Disease
Ilie, I. R. P., Ilie, R., MOCAN, L. C., Georgescu, C. E., Duncea, I., Mocan, T., Ghibu, S., & Iancu, C. (2012) · InTech eBooks · doi:10.5772/32072 · Cited by 1
Haydardedeoğlu, F. E., Haydardedeoğlu, B., Kozanoğlu, İ., Tutuncu, N., Anaforoğlu, İ., & Ertörer, M. E. (2014) · IVF Lite · doi:10.4103/2348-2907.140126 · Cited by 1
Boyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Polycystic Ovary Syndrome, Obesity and Insulin Resistance
Cassar, S. (2014) · Victoria University Research Repository (Victoria University) · Cited by 1
Risco de Farmingham e evento cardiovascular em mulheres com síndrome dos ovários policísticos
Santos, A. G. (2014) · Americanae (AECID Library) · Cited by 1
Aye, M. M. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1
Pasquali, R., & Gambineri, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_4
Markers for Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome and Controls
Meyer, M. L. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Polycystic Ovary Syndrome and Cardiovascular Disease
nder, B., Taner, D., Ylmaz, H., & Muzaffer, M. (2012) · InTech eBooks · doi:10.5772/25519
Insulin Action and Secretion in Polycystic Ovary Syndrome
Warren-Ulanch, J., & Arslanian, S. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_11
Dagre, A. G., Lekakis, J., Mihas, C. C., Protogerou, A. D., Thalassinou, L., Tryfonopoulos, D. J., Douridas, G., Papamichael, C. M., & Alevizaki, M. K. (2011)
Best Practice & Research Clinical Obstetrics and Gynaecology
Talmor, A. J., & Dunphy, B. C. (2015)
Metadata
- Authors
- Meyer, C., McGrath, B. P., Cameron, J., Kotsopoulos, D., & Teede, H. J.
- Affiliations
- Dandenong Hospital (AU)
- Corresponding author
- Teede, H. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-08-01
- Volume
- 90
- Issue
- 8
- Pages
- 4630-4635
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1992054212
- Cited by
- 101
- References
- 38
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 6 · 2016: 2 · 2015: 7 · 2014: 8 · 2013: 4 · 2012: 5
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- polycystic ovary syndrome, insulin resistance, cardiovascular risk, carotid intima-media thickness, flow-mediated dilation, pulse wave velocity, endothelial function, arterial stiffness, dehydroepiandrosterone sulfate, blood pressure, fasting blood glucose, serum lipids, metabolic syndrome, overweight women
- MeSH terms
- Adolescent, Adult, Androgens, Carotid Artery Diseases, Endothelium, Vascular, Female, Humans, Insulin Resistance, Middle Aged, Obesity, Polycystic Ovary Syndrome, Pulsatile Flow, Regression Analysis, Ultrasonography, Vasodilation, Blood Pressure Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
